Acción BEACONPHAR BEACON PHARMACEUTICALS PLC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Beacon Pharmaceuticals PLC

Acciones

BEACONPHAR

BD0482BECON5

Precio de cierre Dhaka S.E.
Otros sitios de cotización
 00:00:00 09/05/2024 		Varia. Cinco días. Varia. 1 de enero.
181,8 BDT -2,99 % Gráfico intradía de Beacon Pharmaceuticals PLC -1,20 % -25,80 %
13/02 Beacon Pharmaceuticals PLC presenta los resultados del segundo trimestre y de los seis meses que finalizaron el 31 de diciembre de 2023 CI
30/01 Beacon Pharmaceuticals plc anuncia el nombramiento de Md. Sahabuddin FCS como Secretario de la Compañía CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Beacon Pharmaceuticals plc Announces Appointment of Md. Sahabuddin FCS as Company Secretary
Beacon Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023
Beacon Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended June 30, 2023
Beacon Pharmaceuticals plc Recommends Cash Dividend for the Year Ended June 30, 2023
Beacon Pharmaceuticals plc Appoints Mr. Ulfat Karim as the Director and Chief Operating Officer
Beacon Pharmaceuticals PLC Announces Appointment of Jalal Uddin as Chief Financial Officer
Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as CFO
Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as Director (Finance & Accounts)
Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Beacon Pharmaceuticals Limited will Change its Name to Beacon Pharmaceuticals PLC
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022
Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021
Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción BEACONPHAR
  4. Noticias Beacon Pharmaceuticals PLC
  5. Otros idiomas